WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 6'8701 Infant (under 12 months) mortality rate: 112
GDP / capita (US$): 15'9331 Child (under 5 years) mortality rate: 122

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 7'278  7'333  7'389  7'446  7'504  8'001  8'821  8'865 
Births 70  70  71  71  71  65  105  133 
Surviving infants 69  70  70  70  70  64  103  130 
Pop. less than 5 years 345  344  340  337  333  330  557  677 
Pop. less than 15 years 986  984  984  987  994  1'254  1'792  1'961 
Female 15-49 years 1'639  1'661  1'685  1'715  1'745  1'936  2'104  2'140 

Number of reported case

(Click for retrospective incidence data for Bulgaria)
Diphtheria
Japanese encephalitis
Measles 157  22'004  2'249  46  147  10'763 
Mumps 58  139  317  1'111  5'582  2'357 
Pertussis 102  46  54  251  193  106  26  154 
Polio* 15 
Rubella 18  41  39  44  58  28'449 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 18 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Bulgaria)
Vaccine year result method % card seen                                                
BCG          97  98  98  98  98  98 
DTP1          96  96  96  96  97  95 
DTP3          95  95  94  94  95  93 
HepB_BD          98  99  99  98  98  98 
HepB3          95  96  95  96  96  94 
Hib3          95  95  91  90 
JapEnc         
MCV          94  94  97  96  96  89 
MCV2          94  94  96  93  94  83 
PCV1          95  96  84 
PCV3          94  94  69 
Pol3          95  95  96  94  96  94 
Rota1         
Rota_last         
Rubella1          94  94  97  96  96 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Bulgaria)
BCG 97  98  98  98  98  98  99  99 
DTP1 96  96  96  96  97  95  99  98 
DTP3 95  95  94  94  95  93  99  98 
HepB3 95  96  95  96  96  94 
Hib3 95  95  91 
MCV 94  95  97  96  96  89  99  98 
PCV3 94  94  69 
Pol3 95  95  94  94  96  94  99  99 
Rota_last

Number of districts in the country 28  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 96
From 80 to 89% 4
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG Birth; 7 months; 7, 11, 17 years; Yes after Manntoux test negative
DTaPHibIPV 2, 3, 4, 16 months; Yes
DTaPIPV 6 years; Yes
HepB Birth; 1, 6 months; Yes
MMR 13 months; 12 years; Yes
Pneumo_conj 2, 3, 4, 12 months; Yes
Rabies Yes As post-exposure prophylaxis
Td 12, 17, 25, 35, 45, 55 years; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR No  No  Yes  No  No  No  No 
What years does the MYP cover? number     2005-2010  2005-2010      NA 
Nº of districts with microplans that include activities to raise immunization coverage number 28  28  28  28  28  28  28 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number 28  28  28  28  28  28  28 
Nº districts with DTP3 coverage >=80% number 28  28  27  27  28  28  28 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  96  96  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 13  13  19  28  17     
% of districts with MCV1 coverage >=95% From 0 to 100% 46  46  68  100  61     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 100  100  100  100  100  100  100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.